Celon Pharma S.A. (WSE:CLN)
Poland · Delayed Price · Currency is PLN 21.35
-0.10 (-0.47%)
At close: Dec 5, 2025
Celon Pharma Market Cap
Celon Pharma has a market cap or net worth of 1.15 billion as of December 5, 2025. Its market cap has decreased by -19.13% in one year.
Market Cap
1.15B
Enterprise Value
1.14B
Revenue
225.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
21.35
Market Cap Chart
Since December 1, 2016, Celon Pharma's market cap has increased from 1.00B to 1.15B, an increase of 14.69%. That is a compound annual growth rate of 1.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 1.15B | -19.28% |
| Dec 30, 2024 | 1.42B | 80.47% |
| Dec 29, 2023 | 789.33M | 10.32% |
| Dec 30, 2022 | 715.51M | -57.68% |
| Dec 30, 2021 | 1.69B | -7.35% |
| Dec 30, 2020 | 1.82B | 2.14% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.66B |
| NEUCA | 3.70B |
| Synektik Spólka Akcyjna | 2.37B |
| Voxel | 1.40B |
| Selvita | 870.05M |
| Ryvu Therapeutics | 670.48M |
| Centrum Medyczne ENEL-MED | 509.05M |
| Scope Fluidics | 463.83M |